Atlas Trials

A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment

Clinical trial NCT02902679 · COMPLETED

Trial details

NCT number
NCT02902679
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
ThrombosisFactor XIRenal ImpairmentESRD (End-Stage Renal Disease)
Start date
2016-11-01
Primary completion
2017-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.